Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Shaun McMeans; Timothy Holtzer; Sam Rua; David Martyr; Thomas Bachmann; Gerard Vaillant

Premium

HTG Molecular has made several new appointments to its executive team. Shaun McMeans has been named vice president of finance, administration, and chief technology officer; Timothy Holtzer has been named vice president of clinical diagnostic development; and Sam Rua has been named vice president of regulatory affairs and quality systems.

McMeans previously was CEO of Securaplane Technologies. Holtzer held various positions related to diagnostics at DiagnoCure, Centocor, and Abbott Laboratories. Rua was formerly vice president of global regulatory and clinical affairs at Beckman Coulter.


David Martyr has been named CEO of Tecan. The Swiss tools vendor said that Martyr will join the firm no later than Oct. 8, 2012, after he fulfills his contractual obligations to Danaher, where he is group executive and vice president. He previously was president of Leica Microsystems until Danaher acquired that firm in 2009.

Martyr succeeds Thomas Bachmann, who had held the position since 2005 and has left the firm. Board member Gerard Vaillant will serve as acting CEO until Martyr is ready to run the firm.

The Scan

Study Reveals New Details About Genetics of Major Cause of Female Infertility

Researchers in Nature Medicine conducted a whole-exome sequencing study of mote than a thousand patients with premature ovarian insufficiency.

Circulating Tumor DNA Shows Potential as Biomarker in Rare Childhood Cancer

A study in the Journal of Clinical Oncology has found that circulating tumor DNA levels in rhabdomyosarcoma may serve as a biomarker for prognosis.

Study Recommends Cancer Screening for Dogs Beginning Age Seven, Depending on Breed

PetDx researchers report in PLOS One that annual cancer screening for dogs should begin by age seven.

White-Tailed Deer Harbor SARS-CoV-2 Variants No Longer Infecting Humans, Study Finds

A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.